文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

美国 HIV 阴性的黑人男同性恋者、双性恋者及其他性少数男性对按需/间歇性/事件驱动型和长效注射用艾滋病毒暴露前预防(PrEP)的偏好:一项定性研究。

Preferences for on-demand/intermittent/event-driven and long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) among HIV-negative Black gay, bisexual, and other sexual minority men in the United States: A qualitative study.

作者信息

Ogunbajo Adedotun, Euceda Alexa, Ekundayo Raven, Smith Jamil, Oke Temitope, Hickson DeMarc

机构信息

Us Helping Us, People into Living Inc., Washington D.C., District of Columbia, United States of America.

出版信息

PLoS One. 2025 Jun 30;20(6):e0323212. doi: 10.1371/journal.pone.0323212. eCollection 2025.


DOI:10.1371/journal.pone.0323212
PMID:40587467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208431/
Abstract

BACKGROUND: Black sexual minority men (SMM) are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a medication that reduces HIV acquisition. There is a gap in our understanding of the acceptability of and preference for on-demand and long-acting injectable (LAI)-PrEP among PrEP-eligible Black SMM. This study aimed to explore preference for on-demand and LAI-PrEP and reasons for those preferences among HIV-negative Black SMM of different PrEP use profiles (current PrEP users, current non-PrEP users, and PrEP discontinuers). METHODS: Between March 2022 and April 2023, we conducted 17 focus group discussions (FGDs) with a total of 58 HIV-negative (current PrEP users, non-PrEP users, and PrEP discontinuers) Black SMM residing in the Washington D.C. metropolitan area. We explored acceptability and interest in on-demand and LAI-PrEP and anticipated barriers and facilitators to uptake. RESULTS: Two key themes emerged around interest and preferences for on-demand PrEP and LAI-PrEP: 1) lack of interest in on-demand PrEP, and 2) high acceptability of LAI-PrEP. The reasons for lack of interest in on-demand PrEP were: 1) inability to accurately anticipate and plan for sexual activity in advance, 2) uncertainty about effectiveness of on-demand PrEP, and 3) potential for unnecessary medication use, especially when anticipated sexual activity doesn't occur. Most participants finding LAI-PrEP to be highly acceptable can be attributable to: 1) LAI-PrEP being convenient, and 2) LAI-PrEP being a potential solution to suboptimal adherence to daily oral PrEP due to forgetfulness. DISCUSSION: While daily oral PrEP is the most utilized PrEP modality, some SMM-who might not be acceptable to oral PrEP-are capable of accurately identifying specific periods and circumstances for HIV infection. It is important that healthcare providers present on-demand PrEP as an option to individuals who fall into these categories. Programs to increase awareness and knowledge of LAI-PrEP among Black SMM and HCP that serve them are needed. Additionally, it is imperative that HCP who provide PrEP services receive proper training on the administration of LAI-PrEP and that there is dedicated staff to help clients navigate the insurance coverage process.

摘要

背景:黑人男同性恋者(SMM)感染艾滋病毒的比例过高。暴露前预防(PrEP)是一种可降低艾滋病毒感染风险的药物。我们对符合PrEP条件的黑人男同性恋者对按需PrEP和长效注射(LAI)-PrEP的可接受性和偏好的了解存在差距。本研究旨在探讨不同PrEP使用情况(当前PrEP使用者、当前非PrEP使用者和PrEP停用者)的艾滋病毒阴性黑人男同性恋者对按需PrEP和LAI-PrEP的偏好及其原因。 方法:2022年3月至2023年4月期间,我们与居住在华盛顿特区大都市区的58名艾滋病毒阴性(当前PrEP使用者、非PrEP使用者和PrEP停用者)黑人男同性恋者进行了17次焦点小组讨论(FGD)。我们探讨了对按需PrEP和LAI-PrEP的可接受性和兴趣,以及预期的采用障碍和促进因素。 结果:围绕对按需PrEP和LAI-PrEP的兴趣和偏好出现了两个关键主题:1)对按需PrEP缺乏兴趣,2)对LAI-PrEP的高接受度。对按需PrEP缺乏兴趣的原因是:1)无法提前准确预测和计划性行为,2)对按需PrEP有效性的不确定性,3)存在不必要用药的可能性,尤其是在预期的性行为未发生时。大多数参与者认为LAI-PrEP非常可接受,这可归因于:1)LAI-PrEP方便,2)LAI-PrEP可能是解决因遗忘而导致每日口服PrEP依从性不佳的潜在方案。 讨论:虽然每日口服PrEP是最常用的PrEP方式,但一些可能无法接受口服PrEP的男同性恋者能够准确识别艾滋病毒感染的特定时期和情况。医疗保健提供者向属于这些类别的个人提供按需PrEP作为一种选择非常重要。需要开展相关项目,以提高黑人男同性恋者和为他们服务的医疗保健提供者对LAI-PrEP的认识和了解。此外,提供PrEP服务的医疗保健提供者必须接受关于LAI-PrEP给药的适当培训,并且要有专门的工作人员帮助客户处理保险覆盖流程。

相似文献

[1]
Preferences for on-demand/intermittent/event-driven and long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) among HIV-negative Black gay, bisexual, and other sexual minority men in the United States: A qualitative study.

PLoS One. 2025-6-30

[2]
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.

J Int AIDS Soc. 2023-7

[3]
PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-word settings among sexual and gender minority adolescents in Brazil.

BMJ Open. 2025-1-20

[4]
Sexual Harassment and Prevention Training

2025-1

[5]
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB-Brasil study.

J Int AIDS Soc. 2025-7

[6]
Preferences for Monthly Oral PrEP Over Other PrEP Modalities Among a National Sample of Gay, Bisexual, and Other Men Who Have Sex With Men in the United States.

J Acquir Immune Defic Syndr. 2025-6-1

[7]
Men's Voices on Long-Acting Pre-Exposure Prophylaxis Delivery Modalities: Acceptability and Preferences Among Cisgender Men and Men Who Have Sex With Men in South Africa.

J Acquir Immune Defic Syndr. 2025-5-1

[8]
Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP.

J Int Assoc Provid AIDS Care. 2024

[9]
Preferences for models of sexual health service delivery among gay, bisexual and other men who have sex with men in Australia: a discrete choice experiment.

J Int AIDS Soc. 2025-7

[10]
"We have our reasons": Exploring the acceptability of pre-exposure prophylaxis among gay, bisexual, and other men who have sex with men in Ghana.

BMC Public Health. 2025-7-3

本文引用的文献

[1]
Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States.

J Acquir Immune Defic Syndr. 2024-4-1

[2]
Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men.

J Int AIDS Soc. 2023-7

[3]
Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.

Clin Infect Dis. 2023-8-22

[4]
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

Lancet HIV. 2022-8

[5]
Who is using PrEP on-demand? Factors associated with PrEP use modality among Black and Hispanic/Latino emerging adults.

AIDS Behav. 2022-10

[6]
Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa.

AIDS Behav. 2022-7

[7]
Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.

J Int AIDS Soc. 2021-8

[8]
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.

N Engl J Med. 2021-8-12

[9]
Predictors of Event-Driven Regimen Choice in Current PrEP Users and Sexual Behavior Characteristics of MSM Receiving Sexual Health Services in New York City.

AIDS Behav. 2021-8

[10]
Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men.

EClinicalMedicine. 2020-12-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索